The growth inhibition observed at 24 hours (ranging from 79% to 83%) underscores the rapid onset of CitAgNPs activity compared to conventional agents like fluconazole
Phase 3: Optimize both (weeks 9-16) Increase AOD 9604 to 300-500mcg daily based on tolerance
Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3
People with liver or kidney disease, G6PD deficiency, iron overload, or known allergies to any components should skip IV antioxidant therapy
Nevertheless, the precise mechanisms behind its targeted distribution, particularly the involvement of transporters, remain incompletely elucidated (Shi et al., 2020
However, these preclinical findings do not establish safety for use during human pregnancy, as species differences in placental transfer and fetal metabolism may exist